NO942920D0 - - Google Patents
Info
- Publication number
- NO942920D0 NO942920D0 NO942920A NO942920A NO942920D0 NO 942920 D0 NO942920 D0 NO 942920D0 NO 942920 A NO942920 A NO 942920A NO 942920 A NO942920 A NO 942920A NO 942920 D0 NO942920 D0 NO 942920D0
- Authority
- NO
- Norway
- Prior art keywords
- integer
- tumors
- group
- phenyl group
- substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83254092A | 1992-02-06 | 1992-02-06 | |
| PCT/US1993/000669 WO1993016044A1 (en) | 1992-02-06 | 1993-01-11 | Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO942920L NO942920L (no) | 1994-08-05 |
| NO942920D0 true NO942920D0 (hu) | 1994-08-05 |
Family
ID=25261950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942920A NO942920L (no) | 1992-02-06 | 1994-08-05 | Reversering av flerlegemiddelresistens med trifenylazasykloalkanderivater |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0643693B1 (hu) |
| JP (1) | JPH07503957A (hu) |
| KR (1) | KR950700248A (hu) |
| AT (1) | ATE182582T1 (hu) |
| AU (1) | AU662602B2 (hu) |
| CA (1) | CA2129144C (hu) |
| DE (1) | DE69325805T2 (hu) |
| DK (1) | DK0643693T3 (hu) |
| ES (1) | ES2135463T3 (hu) |
| GR (1) | GR3031557T3 (hu) |
| HU (1) | HUT70564A (hu) |
| NO (1) | NO942920L (hu) |
| NZ (1) | NZ249040A (hu) |
| WO (1) | WO1993016044A1 (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0680470T3 (hu) * | 1993-01-21 | 1997-04-28 | Merrell Pharma Inc | |
| US5670521A (en) * | 1994-08-05 | 1997-09-23 | Merrell Pharmaceuticals Inc. | Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives |
| EP0777472A2 (en) | 1994-08-31 | 1997-06-11 | Eli Lilly And Company | Methods for identifying and treating resistant tumors |
| TW527186B (en) | 1996-03-19 | 2003-04-11 | Janssen Pharmaceutica Nv | Fused imidazole derivatives as multidrug resistance modulators |
| GB0003685D0 (en) * | 2000-02-17 | 2000-04-05 | Univ Cardiff | Sensitisation of cellular material |
| CN110372571B (zh) * | 2018-04-12 | 2022-11-15 | 中国科学院大连化学物理研究所 | 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1049377B (de) * | 1952-04-03 | 1959-01-29 | Abbott Laboratories, North Chicago, 111. (V. St. A.) | Verfahren zur Herstellung von substituierten Vinylpiperidinen |
| EP0235463A3 (en) * | 1985-12-20 | 1990-01-17 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents |
| IL94768A (en) * | 1989-06-19 | 1995-08-31 | Wellcome Found | Use of Reliable History Transformed by Aril for the Preparation of Pharmaceuticals |
| GB9000305D0 (en) * | 1990-01-06 | 1990-03-07 | Pfizer Ltd | Anticholinergic agents |
| EP0467435A3 (en) * | 1990-07-19 | 1992-04-01 | Akzo N.V. | Benzhydryl derivatives having calmodulin inhibitor properties |
| DK0680470T3 (hu) * | 1993-01-21 | 1997-04-28 | Merrell Pharma Inc |
-
1993
- 1993-01-11 AU AU34842/93A patent/AU662602B2/en not_active Ceased
- 1993-01-11 WO PCT/US1993/000669 patent/WO1993016044A1/en active IP Right Grant
- 1993-01-11 DK DK93903678T patent/DK0643693T3/da active
- 1993-01-11 ES ES93903678T patent/ES2135463T3/es not_active Expired - Lifetime
- 1993-01-11 DE DE69325805T patent/DE69325805T2/de not_active Expired - Fee Related
- 1993-01-11 EP EP93903678A patent/EP0643693B1/en not_active Expired - Lifetime
- 1993-01-11 CA CA002129144A patent/CA2129144C/en not_active Expired - Fee Related
- 1993-01-11 JP JP5514096A patent/JPH07503957A/ja active Pending
- 1993-01-11 HU HU9402298A patent/HUT70564A/hu unknown
- 1993-01-11 AT AT93903678T patent/ATE182582T1/de not_active IP Right Cessation
- 1993-01-11 NZ NZ249040A patent/NZ249040A/en unknown
-
1994
- 1994-08-05 KR KR1019940702687A patent/KR950700248A/ko not_active Application Discontinuation
- 1994-08-05 NO NO942920A patent/NO942920L/no unknown
-
1999
- 1999-10-15 GR GR990402651T patent/GR3031557T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2129144A1 (en) | 1993-08-19 |
| ES2135463T3 (es) | 1999-11-01 |
| GR3031557T3 (en) | 2000-01-31 |
| NZ249040A (en) | 1997-06-24 |
| JPH07503957A (ja) | 1995-04-27 |
| NO942920L (no) | 1994-08-05 |
| DE69325805T2 (de) | 2000-03-16 |
| AU662602B2 (en) | 1995-09-07 |
| WO1993016044A1 (en) | 1993-08-19 |
| DE69325805D1 (de) | 1999-09-02 |
| EP0643693A1 (en) | 1995-03-22 |
| HUT70564A (en) | 1995-10-30 |
| HU9402298D0 (en) | 1994-10-28 |
| KR950700248A (ko) | 1995-01-16 |
| EP0643693B1 (en) | 1999-07-28 |
| DK0643693T3 (da) | 1999-11-29 |
| AU3484293A (en) | 1993-09-03 |
| ATE182582T1 (de) | 1999-08-15 |
| CA2129144C (en) | 1999-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60220188D1 (de) | Hemmer des phosphattransports | |
| CA2230936A1 (en) | 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists | |
| CA2176973A1 (en) | Phenyl Heterocycles as Cyclooxygenase-2 Inhibitors | |
| AR020250A1 (es) | Compueto de isoxazolinona, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion | |
| ES353047A1 (es) | Un procedimiento para preparar un pesticida a base de piri-midina. | |
| CA2074155A1 (en) | Herbicidal 4-acyl-5-arylisoxazoles | |
| NO942920D0 (hu) | ||
| TR200001950T2 (tr) | İkameli 2-benzilamino-2-fenil-asetamid bileşikler. | |
| SE8503466D0 (sv) | Aminofenolforeningar | |
| KR920006350A (ko) | 3-아릴-4(3h)퀴나졸리논 cck 길항물질 및 그의 약학 조성물 | |
| SE8503415D0 (sv) | Novel isoindolinyl-alkyl-piperazines | |
| DK0714387T3 (da) | Hidtil ukendte bis-naphthalimider til behandling af cancer | |
| ATE44648T1 (de) | Antihypertensives kombinationspraeparat. | |
| CO5080754A1 (es) | Caspasas y apoptosis | |
| KR960700230A (ko) | 다중-약물 내성종양 제제로서 유용한 디아릴알킬 피페리딘(Diarylalkyl piperidines useful as multi-drug resistant tumor agents) | |
| SE8006668L (sv) | 2-amino-3-bensoyl-fenylacetamider och cykliska homologer | |
| ES8101637A1 (es) | Procedimiento para la produccion de compuestos fenil-azo-i- sotiazolilo | |
| DE60221360D1 (de) | Herstellung von phthalanen | |
| ATE69611T1 (de) | Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
| TR200100364T2 (tr) | Yeni bileşimler. | |
| PT73173B (de) | Verfahrung zur herstellung von imidazobenzothiadiazepine | |
| DK1592303T3 (da) | Behandling af slam eller opslæmninger | |
| FI910511A0 (fi) | Foerfarande foer framstaellning av substituerade b-diketoner. | |
| DK0532725T3 (da) | Isoxazolderivater som lysfilterpræparater | |
| JPS57145864A (en) | Substituted triazine and its preparation |